Shopping Cart 0
Cart Subtotal
USD 0

Agilent Technologies Inc (A) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers' representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, the UK, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc (A)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 6

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Agilent Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

Agilent Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 11

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 15

Asset Purchase 15

Agilent Technologies Acquires Product Line Of Aurora SFC Systems 15

Venture Financing 16

Molecular Assemblies Raises USD2.3 Million in Seed Financing 16

Partnerships 17

Agilent Technologies Enters into Agreement with University of Southern California 17

Agilent Tech Extends its Agreement with University of Leuven-Center for Human Genetics and University Hospitals Leuven 18

Agilent Technologies Enters into Agreement with Transcriptic 19

Agilent Technologies Enters into Distributuion Agreement with PureHoney Technologies 20

Protea Biosciences Enters into Agreement with Agilent Technologies 21

Agilent Technologies Enters into Agreement with Bioprocessing Technology Institute 22

Dako Enters into Development Agreement with ONO PHARMA for Opdivo 23

Agilent Technologies And CambTEK Enter Into Co-Marketing Agreement For Sample Prep Technologies 24

Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 25

Agilent Technologies Enters Into Co-Marketing Agreement Picometrics 26

Dako Enters Into Co-Development Agreement With Merck 27

Agilent Technologies Enters Into Research Agreement With University of Queensland 28

ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 29

Agilent Enters Into Research Agreement With Daegu Gyeongbuk Institute of Science And Technology 30

Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 31

Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 32

Agilent Technologies Enters Into Agreement With University of Rouen And Bioprocessing Technology Institute For Biologics And Vaccine Analysis 33

Agilent Enters Into Research Agreement With Chungnam National University 34

Agilent Technologies Enters Into Agreement With Applied Proteomics 35

Agilent Technologies Enters Into Research Agreement With Centre for Omic Sciences For Systems Biology 36

Agilent Technologies Enters Into Technology Integration Agreement With Premier Biosoft International 37

Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 38

Agilent Technologies Enters Into Co-Development Agreement With Beijing Genomics Institute 39

Dako Enters Into Co-Development Agreement With Amgen 40

Dako Enters Into Co-Development Agreement With Amgen 41

Pfenex Enters Into Co-Development Agreement With ProZyme 42

Licensing Agreements 43

Dako Enters into Licensing Agreement with OriGene Technologies 43

ProZyme Enters into Licensing Agreement with BiOptic 44

Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 45

Debt Offering 46

Agilent Technologies Completes Public Offering Of Notes Due 2022 For USD 400 Million 46

Acquisition 48

Agilent Technologies Acquires ProZyme 48

Agilent Technologies Acquires Lasergen for USD105 Million 49

Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 50

Agilent Technologies Acquires Cartagenia for USD68.34 Million 51

Agilent Technologies To Acquire ABC Instrumentacion Analitica 52

Agilent Technologies Acquires Minority Stake In Gen9 For USD 21 Million 53

Agilent Technologies Completes Acquisition Of Dako From EQT For USD 2.2 Billion 54

Agilent Technologies Inc-Key Competitors 56

Agilent Technologies Inc-Key Employees 57

Agilent Technologies Inc-Locations And Subsidiaries 59

Head Office 59

Other Locations & Subsidiaries 59

Recent Developments 61

Financial Announcements 61

Aug 14, 2018: Agilent Technologies reports third-quarter fiscal year 2018 financial results 61

May 14, 2018: Agilent Reports Second-Quarter Fiscal Year 2018 Financial Results 63

Feb 14, 2018: Agilent Technologies Reports First-Quarter Fiscal Year 2018 Financial Results 64

Nov 20, 2017: Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results 65

Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 66

Corporate Communications 67

Jul 31, 2018: Agilent announces CFO transition 67

Apr 24, 2018: Agilent Announces Executive Appointments 68

Apr 16, 2018: Agilent Announces Departure of Patrick Kaltenbach 69

Jan 18, 2018: Agilent Technologies Appoints Dow R. Wilson As Board Director 70

Jan 18, 2018: Dow R. Wilson to Join Agilent's Board of Directors 71

Jul 18, 2017: Hans E. Bishop to Join Agilent's Board of Directors 72

Legal and Regulatory 73

Sep 18, 2018: Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents 73

Government and Public Interest 74

Sep 18, 2018: Twist Bioscience Responds to Agilent's Latest Specious Claims 74

Feb 23, 2017: Agilent Technologies CTO Darlene Solomon Elected to National Academy of Engineering 75

Product News 77

Oct 01, 2018: Agilent brings greater clarity and speed to chemical imaging 77

Aug 08, 2018: Agilent first to release software supporting standardized data format for pharmaceutical industry 78

Jun 14, 2018: Agilent Expands Portfolio of Probes for In Situ Hybridization 79

Jun 06, 2017: Agilent Technologies Introduces New GC/Q-TOF System Enabling Greater Exploration of Unknown Chemical Samples 80

Jun 05, 2017: Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer 81

May 01, 2018: Agilent Announces Real-Time, Live-Cell ATP Rate Assay Kit 82

Mar 21, 2017: Agilent Technologies Enhances Exome Sequencing for Clinical Research 83

Mar 08, 2017: Agilent Technologies Launches New Research-Grade Triple Quadrupole LC/MS System 84

Mar 07, 2017: Agilent Technologies Extends Biopharma Portfolio with Advanced Mass Spec System 85

Other Significant Developments 86

Jun 04, 2018: Agilent Insources to Optimize Logistics Operations 86

Oct 17, 2017: Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research 87

Appendix 88

Methodology 88

About GlobalData 88

Contact Us 88

Disclaimer 88


List Of Figure

List of Figures

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

Agilent Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Agilent Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Agilent Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 10

Agilent Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 11

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Agilent Technologies Acquires Product Line Of Aurora SFC Systems 15

Molecular Assemblies Raises USD2.3 Million in Seed Financing 16

Agilent Technologies Enters into Agreement with University of Southern California 17

Agilent Tech Extends its Agreement with University of Leuven-Center for Human Genetics and University Hospitals Leuven 18

Agilent Technologies Enters into Agreement with Transcriptic 19

Agilent Technologies Enters into Distributuion Agreement with PureHoney Technologies 20

Protea Biosciences Enters into Agreement with Agilent Technologies 21

Agilent Technologies Enters into Agreement with Bioprocessing Technology Institute 22

Dako Enters into Development Agreement with ONO PHARMA for Opdivo 23

Agilent Technologies And CambTEK Enter Into Co-Marketing Agreement For Sample Prep Technologies 24

Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 25

Agilent Technologies Enters Into Co-Marketing Agreement Picometrics 26

Dako Enters Into Co-Development Agreement With Merck 27

Agilent Technologies Enters Into Research Agreement With University of Queensland 28

ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 29

Agilent Enters Into Research Agreement With Daegu Gyeongbuk Institute of Science And Technology 30

Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 31

Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 32

Agilent Technologies Enters Into Agreement With University of Rouen And Bioprocessing Technology Institute For Biologics And Vaccine Analysis 33

Agilent Enters Into Research Agreement With Chungnam National University 34

Agilent Technologies Enters Into Agreement With Applied Proteomics 35

Agilent Technologies Enters Into Research Agreement With Centre for Omic Sciences For Systems Biology 36

Agilent Technologies Enters Into Technology Integration Agreement With Premier Biosoft International 37

Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 38

Agilent Technologies Enters Into Co-Development Agreement With Beijing Genomics Institute 39

Dako Enters Into Co-Development Agreement With Amgen 40

Dako Enters Into Co-Development Agreement With Amgen 41

Pfenex Enters Into Co-Development Agreement With ProZyme 42

Dako Enters into Licensing Agreement with OriGene Technologies 43

ProZyme Enters into Licensing Agreement with BiOptic 44

Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 45

Agilent Technologies Completes Public Offering Of Notes Due 2022 For USD 400 Million 46

Agilent Technologies Acquires ProZyme 48

Agilent Technologies Acquires Lasergen for USD105 Million 49

Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 50

Agilent Technologies Acquires Cartagenia for USD68.34 Million 51

Agilent Technologies To Acquire ABC Instrumentacion Analitica 52

Agilent Technologies Acquires Minority Stake In Gen9 For USD 21 Million 53

Agilent Technologies Completes Acquisition Of Dako From EQT For USD 2.2 Billion 54

Agilent Technologies Inc, Key Competitors 56

Agilent Technologies Inc, Key Employees 57

Agilent Technologies Inc, Subsidiaries 59

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Agilent Technologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers' representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, the UK, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc (A)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 6

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Agilent Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

Agilent Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 11

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 15

Asset Purchase 15

Agilent Technologies Acquires Product Line Of Aurora SFC Systems 15

Venture Financing 16

Molecular Assemblies Raises USD2.3 Million in Seed Financing 16

Partnerships 17

Agilent Technologies Enters into Agreement with University of Southern California 17

Agilent Tech Extends its Agreement with University of Leuven-Center for Human Genetics and University Hospitals Leuven 18

Agilent Technologies Enters into Agreement with Transcriptic 19

Agilent Technologies Enters into Distributuion Agreement with PureHoney Technologies 20

Protea Biosciences Enters into Agreement with Agilent Technologies 21

Agilent Technologies Enters into Agreement with Bioprocessing Technology Institute 22

Dako Enters into Development Agreement with ONO PHARMA for Opdivo 23

Agilent Technologies And CambTEK Enter Into Co-Marketing Agreement For Sample Prep Technologies 24

Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 25

Agilent Technologies Enters Into Co-Marketing Agreement Picometrics 26

Dako Enters Into Co-Development Agreement With Merck 27

Agilent Technologies Enters Into Research Agreement With University of Queensland 28

ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 29

Agilent Enters Into Research Agreement With Daegu Gyeongbuk Institute of Science And Technology 30

Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 31

Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 32

Agilent Technologies Enters Into Agreement With University of Rouen And Bioprocessing Technology Institute For Biologics And Vaccine Analysis 33

Agilent Enters Into Research Agreement With Chungnam National University 34

Agilent Technologies Enters Into Agreement With Applied Proteomics 35

Agilent Technologies Enters Into Research Agreement With Centre for Omic Sciences For Systems Biology 36

Agilent Technologies Enters Into Technology Integration Agreement With Premier Biosoft International 37

Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 38

Agilent Technologies Enters Into Co-Development Agreement With Beijing Genomics Institute 39

Dako Enters Into Co-Development Agreement With Amgen 40

Dako Enters Into Co-Development Agreement With Amgen 41

Pfenex Enters Into Co-Development Agreement With ProZyme 42

Licensing Agreements 43

Dako Enters into Licensing Agreement with OriGene Technologies 43

ProZyme Enters into Licensing Agreement with BiOptic 44

Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 45

Debt Offering 46

Agilent Technologies Completes Public Offering Of Notes Due 2022 For USD 400 Million 46

Acquisition 48

Agilent Technologies Acquires ProZyme 48

Agilent Technologies Acquires Lasergen for USD105 Million 49

Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 50

Agilent Technologies Acquires Cartagenia for USD68.34 Million 51

Agilent Technologies To Acquire ABC Instrumentacion Analitica 52

Agilent Technologies Acquires Minority Stake In Gen9 For USD 21 Million 53

Agilent Technologies Completes Acquisition Of Dako From EQT For USD 2.2 Billion 54

Agilent Technologies Inc-Key Competitors 56

Agilent Technologies Inc-Key Employees 57

Agilent Technologies Inc-Locations And Subsidiaries 59

Head Office 59

Other Locations & Subsidiaries 59

Recent Developments 61

Financial Announcements 61

Aug 14, 2018: Agilent Technologies reports third-quarter fiscal year 2018 financial results 61

May 14, 2018: Agilent Reports Second-Quarter Fiscal Year 2018 Financial Results 63

Feb 14, 2018: Agilent Technologies Reports First-Quarter Fiscal Year 2018 Financial Results 64

Nov 20, 2017: Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results 65

Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 66

Corporate Communications 67

Jul 31, 2018: Agilent announces CFO transition 67

Apr 24, 2018: Agilent Announces Executive Appointments 68

Apr 16, 2018: Agilent Announces Departure of Patrick Kaltenbach 69

Jan 18, 2018: Agilent Technologies Appoints Dow R. Wilson As Board Director 70

Jan 18, 2018: Dow R. Wilson to Join Agilent's Board of Directors 71

Jul 18, 2017: Hans E. Bishop to Join Agilent's Board of Directors 72

Legal and Regulatory 73

Sep 18, 2018: Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents 73

Government and Public Interest 74

Sep 18, 2018: Twist Bioscience Responds to Agilent's Latest Specious Claims 74

Feb 23, 2017: Agilent Technologies CTO Darlene Solomon Elected to National Academy of Engineering 75

Product News 77

Oct 01, 2018: Agilent brings greater clarity and speed to chemical imaging 77

Aug 08, 2018: Agilent first to release software supporting standardized data format for pharmaceutical industry 78

Jun 14, 2018: Agilent Expands Portfolio of Probes for In Situ Hybridization 79

Jun 06, 2017: Agilent Technologies Introduces New GC/Q-TOF System Enabling Greater Exploration of Unknown Chemical Samples 80

Jun 05, 2017: Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer 81

May 01, 2018: Agilent Announces Real-Time, Live-Cell ATP Rate Assay Kit 82

Mar 21, 2017: Agilent Technologies Enhances Exome Sequencing for Clinical Research 83

Mar 08, 2017: Agilent Technologies Launches New Research-Grade Triple Quadrupole LC/MS System 84

Mar 07, 2017: Agilent Technologies Extends Biopharma Portfolio with Advanced Mass Spec System 85

Other Significant Developments 86

Jun 04, 2018: Agilent Insources to Optimize Logistics Operations 86

Oct 17, 2017: Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research 87

Appendix 88

Methodology 88

About GlobalData 88

Contact Us 88

Disclaimer 88


List Of Figure

List of Figures

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

Agilent Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Agilent Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Agilent Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 10

Agilent Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 11

Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Agilent Technologies Acquires Product Line Of Aurora SFC Systems 15

Molecular Assemblies Raises USD2.3 Million in Seed Financing 16

Agilent Technologies Enters into Agreement with University of Southern California 17

Agilent Tech Extends its Agreement with University of Leuven-Center for Human Genetics and University Hospitals Leuven 18

Agilent Technologies Enters into Agreement with Transcriptic 19

Agilent Technologies Enters into Distributuion Agreement with PureHoney Technologies 20

Protea Biosciences Enters into Agreement with Agilent Technologies 21

Agilent Technologies Enters into Agreement with Bioprocessing Technology Institute 22

Dako Enters into Development Agreement with ONO PHARMA for Opdivo 23

Agilent Technologies And CambTEK Enter Into Co-Marketing Agreement For Sample Prep Technologies 24

Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 25

Agilent Technologies Enters Into Co-Marketing Agreement Picometrics 26

Dako Enters Into Co-Development Agreement With Merck 27

Agilent Technologies Enters Into Research Agreement With University of Queensland 28

ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 29

Agilent Enters Into Research Agreement With Daegu Gyeongbuk Institute of Science And Technology 30

Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 31

Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 32

Agilent Technologies Enters Into Agreement With University of Rouen And Bioprocessing Technology Institute For Biologics And Vaccine Analysis 33

Agilent Enters Into Research Agreement With Chungnam National University 34

Agilent Technologies Enters Into Agreement With Applied Proteomics 35

Agilent Technologies Enters Into Research Agreement With Centre for Omic Sciences For Systems Biology 36

Agilent Technologies Enters Into Technology Integration Agreement With Premier Biosoft International 37

Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 38

Agilent Technologies Enters Into Co-Development Agreement With Beijing Genomics Institute 39

Dako Enters Into Co-Development Agreement With Amgen 40

Dako Enters Into Co-Development Agreement With Amgen 41

Pfenex Enters Into Co-Development Agreement With ProZyme 42

Dako Enters into Licensing Agreement with OriGene Technologies 43

ProZyme Enters into Licensing Agreement with BiOptic 44

Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 45

Agilent Technologies Completes Public Offering Of Notes Due 2022 For USD 400 Million 46

Agilent Technologies Acquires ProZyme 48

Agilent Technologies Acquires Lasergen for USD105 Million 49

Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 50

Agilent Technologies Acquires Cartagenia for USD68.34 Million 51

Agilent Technologies To Acquire ABC Instrumentacion Analitica 52

Agilent Technologies Acquires Minority Stake In Gen9 For USD 21 Million 53

Agilent Technologies Completes Acquisition Of Dako From EQT For USD 2.2 Billion 54

Agilent Technologies Inc, Key Competitors 56

Agilent Technologies Inc, Key Employees 57

Agilent Technologies Inc, Subsidiaries 59

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Agilent Technologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat